TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada
Clinical trial NCT00323492 · COMPLETED
Trial details
- NCT number
- NCT00323492
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-07-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.